Join the DDA or

Prescription charge waiver announced for COVID antivirals

Exemption applies to March 31, 2023

April 4th 2022

Tagged: Dispensary guidance news England COVID19

By Ailsa Colquhoun

Prescription charges for antiviral medicines to treat COVID-19 will be waived until 31 March 2023, the DHSC has announced.

The waiver applies to the following patients:

  • those who are eligible to receive antiviral treatments for COVID-19 via COVID Medicines Delivery Units (CMDUs)
  • STIMULATE ICP treating community patients for long COVID
  • therapeutic treatments available through the National Institute for Health Research (NIHR) funded HEAL-COVID clinical trial platform treating patients who have been hospitalised for COVID-19.